MDMA-Assisted Therapy for PTSD Edges Toward Acceptance – When Might It Be Approved?
The FDA will have 60 days “to determine whether the MDMA-AT NDA application will be accepted for review and whether it will be a priority or standard review. The estimate timeline is six months or ten months.